| 参考文献: |
1. Todd W. M. (1994). Cefpodoxime proxetil: a comprehensive review. International journal of antimicrobial agents, 4(1), 37–62. 2. Date, A. A., & Nagarsenker, M. S. (2007). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. International journal of pharmaceutics, 329(1-2), 166–172. 3. Borin M. T. (1991). A review of the pharmacokinetics of cefpodoxime proxetil. Drugs, 42 Suppl 3, 13–21. 4. Frampton, J. E., et al., (1992). Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs, 44(5), 889–917. 5. Pahwa R, Rana A S, Dhimans S, et al. Cefpodoxime proxetil: an update on analytical, clinical and pharmacological aspects [J]. J Curr Chem Pharm Sc, 2015, 5(2): 56-66.6. Utsui, Y., et al., (1987). In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrobial agents and chemotherapy, 31(7), 1085–1092. |